They are not for diagnostic, therapeutic, veterinary, or human consumption
Expected timeline: Month 1-2: Inflammation management, symptomatic improvement Month 3-6: Potential slowing of degenerative markers, quality of life improvement Month 6-12: Assessment of structural changes, protocol optimization Ongoing: Maintenance protocols as needed, cycling strategies Complementary approaches: Anti-inflammatory nutrition
[PMID: 15009207] PubMed record related to this compound for laboratory literature review
We treat what's actually holding you back with medically supervised GLP-1 therapy and a plan built around your biology
Balancing your medication with healthy GI transit requires an individualized strategy
Market competition Ozempic v/s Mounjaro While Ozempic hasn't launched in India yet, its patent is nearing expiration in January 2026